Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.

Amazon cuts ties with fertility benefits company Progyny

Amazon is terminating its contract with Progyny, a company that sells fertility benefits such as in vitro fertilization and egg freezing to employers, according to

September 20, 2024

Seasonal influenza triggers significant school closures, especially in southern states, study finds

Study examined closures of United States (US) schools due to 11 influenza seasons between 2011 and 2022.

April 18, 2024

How are insurers handling the Alzheimer’s drug Leqembi and related scans?

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.